These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18959010)

  • 1. [Is justified the use of GIK solutions in acute myocardial infarct?].
    de Micheli A
    Arch Cardiol Mex; 2008; 78(3):243-6. PubMed ID: 18959010
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials.
    Zhao YT; Weng CL; Chen ML; Li KB; Ge YG; Lin XM; Zhao WS; Chen J; Zhang L; Yin JX; Yang XC
    Heart; 2010 Oct; 96(20):1622-6. PubMed ID: 20937749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucose-insulin-potassium solution on acute myocardial infarction outcome in patients received streptokinase according to Killip classes.
    Soltani Z; Samadikhah J; Azarfarin R; Hashemi B; Nezami N
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):372-5. PubMed ID: 20693135
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
    JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Apstein CS
    JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Dey J; Blonde L; Burshell A; Bolton P; Richard A
    JAMA; 2005 Jun; 293(21):2597-8; author reply 2598. PubMed ID: 15928277
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Cobb LA; Killip T; Lambrew CT; MacLeod BA; Rackley CE; Selker HP; Zalenski RJ
    JAMA; 2005 Jun; 293(21):2597; author reply 2598. PubMed ID: 15928278
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.
    Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS
    Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-insulin-potassium therapy in patients with STEMI.
    Chaudhuri A; Nesto R; Dandona P
    JAMA; 2008 May; 299(20):2386-7; author reply 2387-8. PubMed ID: 18505943
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucose-insulin-potassium therapy in patients with STEMI.
    Selker HP; Ingwall J; Rackley CE
    JAMA; 2008 May; 299(20):2385; author reply 2387-8. PubMed ID: 18505942
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose, insulin, and the cardiovascular system.
    Broomhead CJ; Colvin MP
    Heart; 2001 May; 85(5):495-6. PubMed ID: 11302992
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose-insulin-potassium therapy in the era of coronary revascularization.
    Leos CL; Griego JE; Anderson JR
    Cardiol Rev; 2005; 13(5):266-70. PubMed ID: 16106190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic modulation of acute myocardial infarction.
    Diaz R
    Crit Care Clin; 2001 Apr; 17(2):469-76. PubMed ID: 11450327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial.
    Ceremuzyński L; Budaj A; Czepiel A; Burzykowski T; Achremczyk P; Smielak-Korombel W; Maciejewicz J; Dziubińska J; Nartowicz E; Kawka-Urbanek T; Piotrowski W; Hanzlik J; Cieśliński A; Kawecka-Jaszcz K; Gessek J; Wrabec K
    Cardiovasc Drugs Ther; 1999 May; 13(3):191-200. PubMed ID: 10439881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial.
    Apstein CS
    Circulation; 1998 Nov; 98(21):2223-6. PubMed ID: 9826307
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value.
    Apstein CS; Opie LH
    Cardiovasc Drugs Ther; 1999 May; 13(3):185-9. PubMed ID: 10439880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic therapy with glucose-insulin-potassium. Historical outline].
    de Micheli A
    Arch Inst Cardiol Mex; 2000; 70(6):609-15. PubMed ID: 11255721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.